Volume 2, Issue 6, Pages 462-464 (November 2016) Successful treatment of type II pityriasis rubra pilaris with secukinumab Marie-Léa Gauci, MD, Marie Jachiet, MD, Jeremy Gottlieb, MD, Isabelle Madeleine-Chambrin, MD, Michel Rybojad, MD, Martine Bagot, MD, PhD, Jean-David Bouaziz, MD, PhD JAAD Case Reports Volume 2, Issue 6, Pages 462-464 (November 2016) DOI: 10.1016/j.jdcr.2016.09.006 Copyright © 2016 American Academy of Dermatology, Inc. Terms and Conditions
Fig 1 Orange palmoplantar hyperkeratosis. JAAD Case Reports 2016 2, 462-464DOI: (10.1016/j.jdcr.2016.09.006) Copyright © 2016 American Academy of Dermatology, Inc. Terms and Conditions
Fig 2 A, Pityriasis rubra pilaris before secukinumab treatment. B, Pityriasis rubra pilaris 4 weeks after secukinumab treatment. JAAD Case Reports 2016 2, 462-464DOI: (10.1016/j.jdcr.2016.09.006) Copyright © 2016 American Academy of Dermatology, Inc. Terms and Conditions